Insider · CIK 0002017144
Cameron Brooks
officer
Files at AXON (AXON ENTERPRISE, INC.). First filing Jun 2, 2025, latest Jun 2, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $2.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXON: AXON ENTERPRISE, INC.
AXONOct 9, 2026 · close 422.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | AXON ENTERPRISE, INC. | $2.2M 3,000 shares | -13% | +107% from low-0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | AXON AXON ENTERPRISE, INC. | FTax withholding Common Stock | -5,850 | $422.21 | $2.5M | 61,396 | 10 d ago |
| Aug 31, 2026 | AXON AXON ENTERPRISE, INC. | FTax withholding Common Stock | -735 | $566.56 | $416k | 67,246 | 40 d ago |
| Sep 2, 2025 | AXON AXON ENTERPRISE, INC. | FTax withholding Common Stock | -749 | $747.29 | $560k | 18,698 | Sep 3, 2025 |
| May 30, 2025 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock | -3,000 | $740.77 | $2.2M | 19,447 | Jun 2, 2025 |
| May 13, 2025 | AXON AXON ENTERPRISE, INC. | FTax withholding Common Stock | -1,268 | $724.77 | $919k | 22,447 | May 22, 2025 |
| May 13, 2025 | AXON AXON ENTERPRISE, INC. | FTax withholding Common Stock | -3,444 | $724.77 | $2.5M | 20,271 | May 15, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.